Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.
about
A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis.3D Differentiation of LUHMES Cell Line to Study Recovery and Delayed Neurotoxic Effects.Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: Implications for mitochondria mediated oxidative stress signaling events.NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease
P2860
Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.
@en
type
label
Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.
@en
prefLabel
Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.
@en
P2093
P2860
P356
P1476
Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.
@en
P2093
Min-Hua Zhang
Xiao-Min Zhang
P2860
P2888
P304
P356
10.1038/APS.2014.36
P577
2014-07-01T00:00:00Z
P5875
P6179
1032850714